Literature DB >> 23180054

[Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: prevention, diagnostics and therapy].

S Wolf1, K E Wartenberg.   

Abstract

Delayed cerebral ischemia (DCI) is the second most important impacting factor for functional outcome after aneurysmal subarachnoid hemorrhage (SAH) following the initial severity of the bleeding. In contrast to the initial SAH severity the presence and consequences of DCI can be managed with prophylactic and therapeutic interventions. The previous notion of treatment of angiographically observed vasospasm has not been shown to be successful.This article covers prevention, monitoring and therapeutic concepts for patients with SAH with emphasis on the efficacy for DCI and current and ongoing research projects.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23180054     DOI: 10.1007/s00115-012-3528-3

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  41 in total

1.  Lumbar drainage of cerebrospinal fluid after aneurysmal subarachnoid hemorrhage: a prospective, randomized, controlled trial (LUMAS).

Authors:  Yahia Z Al-Tamimi; Deepti Bhargava; Richard G Feltbower; Gregory Hall; Anthony J P Goddard; Audrey C Quinn; Stuart A Ross
Journal:  Stroke       Date:  2012-01-26       Impact factor: 7.914

Review 2.  Anemia and transfusion after subarachnoid hemorrhage.

Authors:  Peter D Le Roux
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

Review 3.  Vasospasm versus delayed cerebral ischemia as an outcome event in clinical trials and observational studies.

Authors:  Mervyn D I Vergouwen
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

4.  Dobutamine-induced high cardiac index did not prevent vasospasm in subarachnoid hemorrhage patients: a randomized controlled pilot study.

Authors:  Nelly Rondeau; Raphaël Cinotti; Bertrand Rozec; Antoine Roquilly; Hervé Floch; Nicolas Groleau; Patrick Michel; Karim Asehnoune; Yvonnick Blanloeil
Journal:  Neurocrit Care       Date:  2012-10       Impact factor: 3.210

Review 5.  Summary of evidence on immediate statins therapy following aneurysmal subarachnoid hemorrhage.

Authors:  M Y Tseng
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

6.  Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association.

Authors:  E Sander Connolly; Alejandro A Rabinstein; J Ricardo Carhuapoma; Colin P Derdeyn; Jacques Dion; Randall T Higashida; Brian L Hoh; Catherine J Kirkness; Andrew M Naidech; Christopher S Ogilvy; Aman B Patel; B Gregory Thompson; Paul Vespa
Journal:  Stroke       Date:  2012-05-03       Impact factor: 7.914

Review 7.  High-volume centers.

Authors:  P Vespa; Michael N Diringer
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

8.  Early detection of vasospasm after acute subarachnoid hemorrhage using continuous EEG ICU monitoring.

Authors:  P M Vespa; M R Nuwer; C Juhász; M Alexander; V Nenov; N Martin; D P Becker
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1997-12

9.  Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: results of a phase II multicenter, randomized, clinical trial.

Authors:  Marike Zwienenberg-Lee; Jonathan Hartman; Nancy Rudisill; Lori Kennedy Madden; Karen Smith; Joseph Eskridge; David Newell; Bon Verweij; M Ross Bullock; Andrew Baker; William Coplin; Robert Mericle; Jian Dai; David Rocke; J Paul Muizelaar
Journal:  Stroke       Date:  2008-04-17       Impact factor: 7.914

10.  Quantitative continuous EEG for detecting delayed cerebral ischemia in patients with poor-grade subarachnoid hemorrhage.

Authors:  Jan Claassen; Lawrence J Hirsch; Kurt T Kreiter; Evelyn Y Du; E Sander Connolly; Ronald G Emerson; Stephan A Mayer
Journal:  Clin Neurophysiol       Date:  2004-12       Impact factor: 3.708

View more
  1 in total

1.  [Multimodal monitoring in neurointensive care medicine: state of the art].

Authors:  C Dohmen; O W Sakowitz
Journal:  Nervenarzt       Date:  2012-12       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.